🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lee S. Simon

Maryland Department of Natural Resources

ORCID: 0000-0001-5673-807X

Also affiliated with Goodman Research Group (United States)

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group”.

Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group

Seminars in Arthritis and Rheumatism(2021)10.1016/j.semarthrit.2020.09.023
N/A
0.269DataRank · unranked
5 citations

Niti Goel, Peter Tugwell, Dan Devoe, Paula R. Williamson, Caroline B. Terwee +14 more

Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group

Seminars in Arthritis and Rheumatism(2023)10.1016/j.semarthrit.2023.152288
N/A
0.165DataRank · unranked
2 citations

Lee S. Simon, Marieke Voshaar, Pam Richards, Niti Goel, Vibeke Strand +21 more

FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit

Seminars in Arthritis and Rheumatism(2022)10.1016/j.semarthrit.2022.152070
N/A
0DataRank · unranked
29 citations

Silvana Borges, Daniel J. Clauw, Philip G. Conaghan, David T. Felson, Thomas R. Fleming +19 more

Patient engagement in designing, conducting, and disseminating clinical pain research: IMMPACT recommended considerations

Pain(2023)10.1097/j.pain.0000000000003121
N/A
0DataRank · unranked
30 citations

Katherine J. Holzer, Robert D. Kerns, Christin Veasley, Robert H. Dworkin, Dennis C. Turk +32 more

Slow acting medications for progressive and painful knee osteoarthritis. How do we assess the benefit to risk of these potentially novel therapies?

Osteoarthritis and Cartilage Open(2024)10.1016/j.ocarto.2024.100546
N/A
0DataRank · unranked
0 citations

Lee S. Simon, J. Tambiah, N.E. Lane

Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group

Seminars in Arthritis and Rheumatism(2021)10.1016/j.semarthrit.2021.11.004
N/A
0DataRank · unranked
4 citations

Robin Christensen, Jasvinder A. Singh, Nicola Dalbeth, Kenneth G. Saag, William J. Taylor +18 more

Disease modification in osteoarthritis; pathways to drug approval

Osteoarthritis and Cartilage Open(2020)10.1016/j.ocarto.2020.100059
N/A
0DataRank · unranked
47 citations

Tuhina Neogi, Leigh F. Callahan, Joel A. Block, Philip G. Conaghan, Lee S. Simon +3 more